Clinical Trial: [18F]-AraG PET Imaging in LA HNSCC

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07168785) titled '[18F]-AraG PET Imaging in LA HNSCC' on Aug. 27.

Brief Summary: This study will use [18F]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Head and Neck Squamous Cell Carcinoma (HNSCC) Locally Advanced Head and Neck Squamous Cell Carcinoma

Intervention: DRUG: [18F]-AraG radiotracer

[18F]-AraG radiotracer, which occurs on the first and sixteenth day of treatment.

DRUG: Chemotherapy

Concurrent chemoradi...